Piperacillin and Tazobactam Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2026-01-20 · last update 2026-01-20
Manufacturers: Fresenius Kabi USA, LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Piperacillin and Tazobactam, Injection, 2.25 g vial (NDC 65219-434-20) | Fresenius Kabi USA, LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 01/20/2026 Updated 01/20/2026 Discontinued 01/20/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)